Myriad Genetics Inc (MYGN) Institutional Ownership

Ownership Summary

A total of 215 institutions have reported a stake in Myriad Genetics Inc (NASDAQ:MYGN) as of September 2025, according to recent 13F filings with the SEC.

• The percentage of Myriad Genetics owned by institutions changed from 96.4% in June 2025 to 95.2% in September 2025, marking a slight down trend.
• The company experienced a 4.61% quarterly change in institutional shares held, alongside a decrease of 12.24% in total owners annually.
• The latest 13F cycle for Myriad Genetics reveals that of 215 total investors, 106 funds grew their exposure, whereas 79 reduced theirs and 30 made no changes.
• Collectively, institutional investors increased their stake in Myriad Genetics to 88.56Mn shares as of September 2025, a change that is up by 3.90Mn shares quarter on quarter and down 2.11Mn shares year over year.
• As of September 30, 2025, BlackRock, Inc. held Myriad Genetics's largest shareholding position with over 14.88Mn shares, representing 15.99% of total outstanding shares.
• Among the most significant buyers of Myriad Genetics during September 2025 were JACOBS LEVY EQUITY MANAGEMENT, INC (1.49Mn), Assenagon Asset Management S.A. (979.13K), GOLDMAN SACHS GROUP INC (868.33K), ALGERT GLOBAL LLC (732.52K), ROYCE & ASSOCIATES LP (666.84K).
• Leading sellers of Myriad Genetics stock in September 2025 included VANGUARD GROUP INC (1.37Mn), MORGAN STANLEY (937.15K), Qube Research & Technologies Ltd (865.08K), Anson Funds Management LP (841.94K), BALYASNY ASSET MANAGEMENT L.P. (717.84K).
• The top 10 institutional holders of Myriad Genetics for the quarter ending September 2025 included BlackRock, Inc. (14.88Mn), VANGUARD GROUP INC (7.88Mn), STATE STREET CORP (4.98Mn), MILLENNIUM MANAGEMENT LLC (4.75Mn), GLENVIEW CAPITAL MANAGEMENT, LLC (4.59Mn), D. E. Shaw & Co., Inc. (4.56Mn), MORGAN STANLEY (3.62Mn), JACOBS LEVY EQUITY MANAGEMENT, INC (2.44Mn), GEODE CAPITAL MANAGEMENT, LLC (2.23Mn), GOLDMAN SACHS GROUP INC (2.15Mn).